Shepherd Financial Partners LLC Amgen Inc Transaction History

Shepherd Financial Partners LLC

$826 Million
Q3 2024

A detailed history of Shepherd Financial Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Shepherd Financial Partners LLC holds 1,543 shares of AMGN stock, worth $408,108. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,543

Previous 1,382 11.65%

Holding current value

$408,108

Previous $431,000 15.31%

% of portfolio

0.06%

Previous 0.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$309.38 - $337.38 $49,810 - $54,318	161 Added 11.65%	1,543 $497,000
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $17,078 - $20,755	-65 Reduced 4.49%	1,382 $431,000
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $11,561 - $13,956	-43 Reduced 2.89%	1,447 $411,000
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $32,218 - $36,345	-126 Reduced 7.8%	1,490 $429,000
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $1,967 - $2,443	-9 Reduced 0.55%	1,616 $434,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $3,214 - $3,800	-15 Reduced 0.91%	1,625 $360,000
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $64,350 - $78,432	285 Added 21.03%	1,640 $396,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $19,925 - $25,317	87 Added 6.86%	1,355 $355,000
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $24,466 - $27,593	109 Added 9.4%	1,268 $286,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $76,365 - $84,980	331 Added 39.98%	1,159 $282,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $181,555 - $200,847	828 New	828 $200,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shepherd Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shepherd Financial Partners LLC with notifications on news.

Account

Shepherd Financial Partners LLC Amgen Inc Transaction History